On International Women's Day two B.Tech students at IIT Delhi, Archit Agarwal and Harry Sehrawat along with Professor Dr. Srinivasan Venkataraman launched what they termed as a solution for period pain relief for women. The product, it was claimed, was tested and had approval from Food and Drug Administration, which is a Federal Agency in United States of America. However, it has come to light that their claims about FDA approval are false.
Earlier, IIT Delhi official website carried a press release which substantiated the claims made by the IIT Delhi incubated startup. The institute since then has edited its release and removed the part about FDA approval.
At the time of the launch of the product, Professor Srinivasan Venkataraman commenting on the need for such a product had said, "Women comprise close to 50% of our population and a significant portion of this population experiences pain and cramps during the menstrual period. Therefore, this becomes an important problem to solve."
(An earlier version of this story had carried the start-up's release on the product which falsely claimed that it was FDA approved.)
Click here for more Education News
